Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.79B | 26.35B | 26.54B | 29.68B | 31.90B | 18.95B |
Gross Profit | 3.00B | 2.90B | 2.71B | 2.80B | 3.29B | 2.38B |
EBITDA | 1.53B | 1.03B | 1.04B | 1.02B | 2.09B | 1.29B |
Net Income | 558.50M | 500.56M | 479.20M | 484.76M | 1.15B | 746.92M |
Balance Sheet | ||||||
Total Assets | 27.39B | 27.40B | 27.20B | 26.18B | 26.34B | 21.54B |
Cash, Cash Equivalents and Short-Term Investments | 262.82M | 246.96M | 574.14M | 314.76M | 102.72M | 132.32M |
Total Debt | 17.92B | 19.22B | 19.53B | 18.93B | 19.27B | 15.53B |
Total Liabilities | 21.10B | 21.16B | 21.12B | 20.57B | 21.10B | 17.18B |
Stockholders Equity | 6.29B | 6.24B | 6.07B | 5.61B | 5.24B | 4.36B |
Cash Flow | ||||||
Free Cash Flow | 540.91M | 156.50M | -6.69M | 860.62M | -2.86B | 503.22M |
Operating Cash Flow | 1.04B | 624.44M | 458.62M | 1.28B | -2.55B | 667.76M |
Investing Cash Flow | -496.32M | -461.00M | -467.00M | -425.77M | -523.75M | -128.18M |
Financing Cash Flow | -470.58M | -453.54M | 307.79M | -710.18M | 3.10B | -424.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $9.01B | 10.91 | 12.95% | 0.62% | 12.96% | -6.25% | |
82 Outperform | $9.01B | 10.91 | 12.95% | 0.62% | 12.96% | -6.25% | |
71 Outperform | $11.97B | 12.75 | 18.57% | 2.79% | 3.29% | -1.29% | |
71 Outperform | $11.97B | 12.75 | 18.57% | 2.79% | 3.29% | -1.29% | |
67 Neutral | $5.00B | 12.10 | 11.92% | ― | 11.11% | -23.41% | |
67 Neutral | $5.00B | 12.10 | 11.92% | ― | 11.11% | -23.41% | |
62 Neutral | C$5.18B | 11.26 | 18.64% | 3.62% | 3.35% | 6.70% | |
60 Neutral | $7.97B | 12.50 | 28.45% | ― | -0.24% | -19.76% | |
60 Neutral | $7.97B | 12.50 | 28.45% | ― | -0.24% | -19.76% | |
59 Neutral | $5.97B | 13.01 | 16.25% | 0.43% | 15.13% | -15.98% | |
59 Neutral | $5.97B | 13.01 | 16.25% | 0.43% | 15.13% | -15.98% | |
55 Neutral | $10.32B | 19.02 | 8.97% | ― | 3.17% | 42.14% |
On June 24, 2025, CarMax held its 2025 Annual Meeting of Shareholders, where several key decisions were made. The shareholders elected directors to the Board for a one-year term, ratified KPMG LLP as the independent registered public accounting firm for fiscal year 2026, and approved a non-binding advisory resolution on executive compensation. However, a shareholder proposal regarding a special meeting right was not approved.
The most recent analyst rating on (KMX) stock is a Sell with a $58.00 price target. To see the full list of analyst forecasts on CarMax stock, see the KMX Stock Forecast page.
On May 9, 2025, CarMax, Inc. announced the departure of James Lyski, its Executive Vice President and Chief Growth and Strategy Officer, effective June 8, 2025. This change in leadership could impact the company’s strategic direction and growth initiatives, as Lyski was a key figure in these areas.
The most recent analyst rating on (KMX) stock is a Sell with a $50.00 price target. To see the full list of analyst forecasts on CarMax stock, see the KMX Stock Forecast page.